These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39289920)

  • 21. Lipid polyunsaturation determines the extent of membrane structural changes induced by Amphotericin B in Pichia pastoris yeast.
    de Ghellinck A; Fragneto G; Laux V; Haertlein M; Jouhet J; Sferrazza M; Wacklin H
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2317-25. PubMed ID: 26055896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
    Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
    Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity.
    Faust O; Abayev-Avraham M; Wentink AS; Maurer M; Nillegoda NB; London N; Bukau B; Rosenzweig R
    Nature; 2020 Nov; 587(7834):489-494. PubMed ID: 33177718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expanding world of plant J-domain proteins.
    Verma AK; Tamadaddi C; Tak Y; Lal SS; Cole SJ; Hines JK; Sahi C
    CRC Crit Rev Plant Sci; 2019; 38(5-6):382-400. PubMed ID: 33223602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
    Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates.
    Francis AP; Gurudevan S; Jayakrishnan A
    J Biomater Sci Polym Ed; 2018 Sep; 29(13):1529-1548. PubMed ID: 29683392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
    Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.
    Mesa-Arango AC; Trevijano-Contador N; Román E; Sánchez-Fresneda R; Casas C; Herrero E; Argüelles JC; Pla J; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6627-38. PubMed ID: 25155595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
    Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of subfunctionalized aggregate-remodeling J-domain proteins in Arabidopsis thaliana.
    Tak Y; Lal SS; Gopan S; Balakrishnan M; Satheesh G; Biswal AK; Verma AK; Cole SJ; Brown RE; Hayward RE; Hines JK; Sahi C
    J Exp Bot; 2023 Mar; 74(5):1705-1722. PubMed ID: 36576197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of client-the scaffold on which FeS clusters are build-with J-domain protein Hsc20 and its evolving Hsp70 partners.
    Marszalek J; Craig EA
    Front Mol Biosci; 2022; 9():1034453. PubMed ID: 36310602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.
    Piette BL; Alerasool N; Lin ZY; Lacoste J; Lam MHY; Qian WW; Tran S; Larsen B; Campos E; Peng J; Gingras AC; Taipale M
    Mol Cell; 2021 Jun; 81(12):2549-2565.e8. PubMed ID: 33957083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
    Neumann A; Baginski M; Czub J
    J Am Chem Soc; 2010 Dec; 132(51):18266-72. PubMed ID: 21126070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmasking the Amphotericin B Resistance Mechanisms in
    Silva LN; Oliveira SSC; Magalhães LB; Andrade Neto VV; Torres-Santos EC; Carvalho MDC; Pereira MD; Branquinha MH; Santos ALS
    ACS Infect Dis; 2020 May; 6(5):1273-1282. PubMed ID: 32239912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between cell wall chitin content and susceptibility to amphotericin B in Kluyveromyces, Candida and Schizosaccharomyces species.
    Bahmed K; Bonaly R; Coulon J
    Res Microbiol; 2003 Apr; 154(3):215-22. PubMed ID: 12706511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro.
    Chudzik B; Czernel G; Miaskowski A; Gagoś M
    Eur J Pharm Sci; 2017 Jan; 97():9-21. PubMed ID: 27816628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data-driven large-scale genomic analysis reveals an intricate phylogenetic and functional landscape in J-domain proteins.
    Malinverni D; Zamuner S; Rebeaud ME; Barducci A; Nillegoda NB; De Los Rios P
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2218217120. PubMed ID: 37523524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
    Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
    Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomewide Elucidation of Drug Resistance Mechanisms for Systemically Used Antifungal Drugs Amphotericin B, Caspofungin, and Voriconazole in the Budding Yeast.
    Balkan C; Ercan I; Isik E; Sahin Akdeniz E; Balcioglu O; Kodedová M; Zimmermannová O; Dundar M; Sychrová H; Koc A
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.